Safety, pharmacokinetics, and pharmacodynamics of single doses of an oral p38 MAP kinase inhibitor (BIRB 796 BS) in healthy human males a placebo-controlled, randomised study, double blinded at each dose level-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety, pharmacokinetics, and pharmacodynamics of single doses of an oral p38 MAP kinase inhibitor (BIRB 796 BS) in healthy human males a placebo-controlled, randomised study, double blinded at each dose level

Published:2002-01 Issue:1 Volume:109 Page:S67-S67
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Gupta Abhya,Yong Chan-Loi,Madwed Jeffrey B,Staehle Hildegard,Wood Chester C

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of protein flexibility in molecular recognition: a case study on Type-I1/2 inhibitors of ALK;Physical Chemistry Chemical Physics;2018

2. Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK);Journal of Medicinal Chemistry;2016-04-12

3. The design and synthesis of novel α-ketoamide-based p38 MAP kinase inhibitors;Bioorganic & Medicinal Chemistry Letters;2008-03

4. Rheumatoid Arthritis;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15

5. Crohn's Disease;Wiley Handbook of Current and Emerging Drug Therapies;2006-09-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP